| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | FOXO1 FOXO3 NOC2L KAT6A HMGA1 KDM6B MBD6 MEOX1 JARID2 H1-8 RCOR1 TNRC18 BRD2 MCM9 TSPYL5 MLLT6 FOXO4 PHF10 LCOR | 2.76e-08 | 739 | 112 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | FOXO1 FOXO3 BDP1 MYBBP1A NOC2L KAT6A HMGA1 TWIST1 JARID2 IGHMBP2 CTDP1 FOXO4 LCOR TP53BP1 | 8.19e-05 | 753 | 112 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | collagen binding | 9.26e-05 | 81 | 112 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | demethylase activity | 1.07e-04 | 44 | 112 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | histone binding | 1.25e-04 | 265 | 112 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXE1 FOXO1 FOXO3 MYBBP1A CEBPD POU2F2 CC2D1B ZNF362 HMGA1 KDM6B TWIST1 MEOX1 ZGPAT KDM2B FOXO4 ZFHX3 MGA IRX2 | 1.88e-04 | 1244 | 112 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXE1 FOXO1 FOXO3 MYBBP1A CEBPD POU2F2 CC2D1B ZNF362 HMGA1 KDM6B TWIST1 MEOX1 ZGPAT KDM2B FOXO4 ZFHX3 MGA IRX2 | 2.44e-04 | 1271 | 112 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | collagen V binding | 3.08e-04 | 5 | 112 | 2 | GO:0070052 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.11e-04 | 229 | 112 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FOXO1 FOXO3 CEBPD POU2F2 HMGA1 CASZ1 TWIST1 MEOX1 FOXO4 MGA ZNF292 | 3.11e-04 | 560 | 112 | 11 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FOXO1 FOXO3 CEBPD POU2F2 HMGA1 CASZ1 TWIST1 MEOX1 FOXO4 MGA ZNF292 | 3.41e-04 | 566 | 112 | 11 | GO:0001216 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXE1 FOXO1 FOXO3 MYBBP1A CEBPD POU2F2 CC2D1B ZNF362 HMGA1 KDM6B CASZ1 TWIST1 MEOX1 ZGPAT KDM2B FOXO4 ZFHX3 MGA IRX2 | 4.64e-04 | 1459 | 112 | 19 | GO:0000977 |
| GeneOntologyMolecularFunction | beta-catenin binding | 5.79e-04 | 120 | 112 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | ubiquitin-modified histone reader activity | 6.43e-04 | 7 | 112 | 2 | GO:0061649 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 6.89e-04 | 31 | 112 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 7.57e-04 | 32 | 112 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | laminin binding | 9.06e-04 | 34 | 112 | 3 | GO:0043236 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.16e-03 | 140 | 112 | 5 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | MYBBP1A NOC2L KAT6A HMGA1 SRCAP RCOR1 KDM2B PHF10 LCOR TP53BP1 | 1.25e-03 | 562 | 112 | 10 | GO:0003712 |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 1.36e-03 | 10 | 112 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MYBBP1A MAP1A NOC2L KAT6A ZC3H18 HMGA1 SRCAP JARID2 RCOR1 PXN KDM2B COL14A1 PHF10 LCOR TP53BP1 | 2.08e-03 | 1160 | 112 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | myosin II binding | 2.34e-03 | 13 | 112 | 2 | GO:0045159 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 2.43e-03 | 326 | 112 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 2.94e-03 | 51 | 112 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.94e-03 | 51 | 112 | 3 | GO:0043394 | |
| GeneOntologyBiologicalProcess | chromatin organization | MYBBP1A KMT2B NOC2L KAT6A HMGA1 KDM6B SRCAP JARID2 H1-8 RCOR1 BRD2 MKI67 KDM2B TSPYL5 MLLT6 PHF10 LCOR TP53BP1 | 1.35e-06 | 896 | 111 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 MYBBP1A KMT2B NOC2L KAT6A HMGA1 KDM6B SRCAP JARID2 H1-8 RCOR1 BRD2 MKI67 KDM2B TSPYL5 MLLT6 PHF10 LCOR TP53BP1 | 1.49e-06 | 999 | 111 | 19 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | MYBBP1A KMT2B NOC2L KAT6A HMGA1 KDM6B SRCAP JARID2 H1-8 BRD2 KDM2B TSPYL5 PHF10 LCOR | 4.42e-05 | 741 | 111 | 14 | GO:0006338 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FOXE1 FOXO1 FOXO3 MYBBP1A CEBPD NOC2L KAT6A CC2D1B HMGA1 TWIST1 JARID2 ZGPAT ZNF469 RCOR1 IGHMBP2 KDM2B ZFHX3 IRX2 LCOR WDTC1 | 5.20e-05 | 1399 | 111 | 20 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FOXE1 FOXO1 FOXO3 MYBBP1A CEBPD NOC2L KAT6A CC2D1B HMGA1 TWIST1 JARID2 ZGPAT ZNF469 RCOR1 IGHMBP2 KDM2B ZFHX3 IRX2 LCOR WDTC1 | 5.98e-05 | 1413 | 111 | 20 | GO:1902679 |
| GeneOntologyBiologicalProcess | response to water-immersion restraint stress | 8.58e-05 | 3 | 111 | 2 | GO:1990785 | |
| GeneOntologyCellularComponent | chromatin | FOXE1 FOXO1 FOXO3 NCAPD3 MYBBP1A CEBPD NOC2L KAT6A POU2F2 HMGA1 SRCAP CASZ1 TWIST1 MEOX1 JARID2 ZGPAT H1-8 BRD2 PDS5A TSPYL5 FOXO4 ZFHX3 MGA IRX2 PHF10 | 3.12e-07 | 1480 | 114 | 25 | GO:0000785 |
| Domain | FOXO-TAD | 2.04e-07 | 3 | 111 | 3 | IPR032067 | |
| Domain | FOXO-TAD | 2.04e-07 | 3 | 111 | 3 | PF16676 | |
| Domain | AT_hook | 1.87e-05 | 27 | 111 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.87e-05 | 27 | 111 | 4 | IPR017956 | |
| Domain | FOXO_KIX-bd | 3.50e-05 | 2 | 111 | 2 | IPR032068 | |
| Domain | FOXO_KIX_bdg | 3.50e-05 | 2 | 111 | 2 | PF16675 | |
| Domain | Znf_PHD-finger | 1.08e-04 | 79 | 111 | 5 | IPR019787 | |
| Domain | AT_hook | 1.08e-04 | 16 | 111 | 3 | PF02178 | |
| Domain | TF_fork_head_CS_2 | 1.59e-04 | 46 | 111 | 4 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 1.73e-04 | 47 | 111 | 4 | IPR018122 | |
| Domain | PHD | 1.89e-04 | 89 | 111 | 5 | SM00249 | |
| Domain | FH | 2.04e-04 | 49 | 111 | 4 | SM00339 | |
| Domain | FORK_HEAD_1 | 2.04e-04 | 49 | 111 | 4 | PS00657 | |
| Domain | FORK_HEAD_2 | 2.04e-04 | 49 | 111 | 4 | PS00658 | |
| Domain | Fork_head_dom | 2.04e-04 | 49 | 111 | 4 | IPR001766 | |
| Domain | FORK_HEAD_3 | 2.04e-04 | 49 | 111 | 4 | PS50039 | |
| Domain | Forkhead | 2.04e-04 | 49 | 111 | 4 | PF00250 | |
| Domain | Furin-like_2 | 2.08e-04 | 4 | 111 | 2 | PF15913 | |
| Domain | Znf_PHD | 2.10e-04 | 91 | 111 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.56e-04 | 95 | 111 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 2.69e-04 | 96 | 111 | 5 | PS01359 | |
| Domain | - | 3.26e-04 | 218 | 111 | 7 | 1.10.10.10 | |
| Domain | TSPN | 3.32e-04 | 23 | 111 | 3 | SM00210 | |
| Domain | JmjC | 3.78e-04 | 24 | 111 | 3 | PF02373 | |
| Domain | Laminin_G | 3.92e-04 | 58 | 111 | 4 | IPR001791 | |
| Domain | TSP1 | 6.05e-04 | 65 | 111 | 4 | SM00209 | |
| Domain | TSP1_rpt | 6.05e-04 | 65 | 111 | 4 | IPR000884 | |
| Domain | TSP1 | 6.05e-04 | 65 | 111 | 4 | PS50092 | |
| Domain | WHTH_DNA-bd_dom | 6.09e-04 | 242 | 111 | 7 | IPR011991 | |
| Domain | HMGI/Y_DNA-bd_CS | 8.13e-04 | 31 | 111 | 3 | IPR000637 | |
| Domain | JMJC | 8.94e-04 | 32 | 111 | 3 | PS51184 | |
| Domain | JmjC_dom | 8.94e-04 | 32 | 111 | 3 | IPR003347 | |
| Domain | JmjC | 9.79e-04 | 33 | 111 | 3 | SM00558 | |
| Domain | PHD | 1.04e-03 | 75 | 111 | 4 | PF00628 | |
| Domain | Znf_FYVE_PHD | 1.85e-03 | 147 | 111 | 5 | IPR011011 | |
| Domain | ZF_CXXC | 1.86e-03 | 11 | 111 | 2 | PS51058 | |
| Domain | PNMA | 1.86e-03 | 11 | 111 | 2 | IPR026523 | |
| Domain | Znf_CXXC | 1.86e-03 | 11 | 111 | 2 | IPR002857 | |
| Domain | zf-CXXC | 1.86e-03 | 11 | 111 | 2 | PF02008 | |
| Domain | PNMA | 1.86e-03 | 11 | 111 | 2 | PF14893 | |
| Domain | Single_hybrid_motif | 2.22e-03 | 12 | 111 | 2 | IPR011053 | |
| Domain | H15 | 2.62e-03 | 13 | 111 | 2 | SM00526 | |
| Domain | H15 | 2.62e-03 | 13 | 111 | 2 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 3.04e-03 | 14 | 111 | 2 | IPR005818 | |
| Domain | Homeodomain-like | 3.69e-03 | 332 | 111 | 7 | IPR009057 | |
| Domain | ARM-type_fold | 4.14e-03 | 339 | 111 | 7 | IPR016024 | |
| Domain | Rib_L2_dom2 | 5.03e-03 | 18 | 111 | 2 | IPR014722 | |
| Domain | - | 5.03e-03 | 18 | 111 | 2 | 2.30.30.30 | |
| Domain | Furin_repeat | 5.03e-03 | 18 | 111 | 2 | IPR006212 | |
| Domain | FU | 5.03e-03 | 18 | 111 | 2 | SM00261 | |
| Domain | BRCT | 5.60e-03 | 19 | 111 | 2 | PF00533 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 6.06e-06 | 7 | 80 | 3 | MM15661 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 2.05e-05 | 10 | 80 | 3 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 2.05e-05 | 10 | 80 | 3 | MM14778 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 2.05e-05 | 10 | 80 | 3 | M27945 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.28e-05 | 65 | 80 | 5 | M39682 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 3.73e-05 | 12 | 80 | 3 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 3.73e-05 | 12 | 80 | 3 | M27939 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 9.34e-05 | 16 | 80 | 3 | M27940 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 1.13e-04 | 17 | 80 | 3 | M27946 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 1.56e-04 | 431 | 80 | 10 | M39729 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | FOXO1 FOXO3 BDP1 MYBBP1A KMT2B NOC2L POLR2E KAT6A POU2F2 PSMD3 THOC2 JARID2 CTDP1 FOXO4 ZFHX3 MGA | 1.69e-04 | 1022 | 80 | 16 | MM15436 |
| Pathway | WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS | 2.51e-04 | 22 | 80 | 3 | M39414 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 2.51e-04 | 22 | 80 | 3 | M15258 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 2.51e-04 | 22 | 80 | 3 | MM15656 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 3.27e-04 | 24 | 80 | 3 | MM14773 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 4.16e-04 | 26 | 80 | 3 | MM1345 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER | 4.16e-04 | 26 | 80 | 3 | M27558 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 4.16e-04 | 26 | 80 | 3 | M32 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 4.16e-04 | 26 | 80 | 3 | M708 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 4.70e-04 | 6 | 80 | 2 | MM15660 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES | 6.40e-04 | 30 | 80 | 3 | M27941 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 7.75e-04 | 32 | 80 | 3 | M39445 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.01e-03 | 35 | 80 | 3 | M249 | |
| Pathway | WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS | 1.01e-03 | 35 | 80 | 3 | M39430 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 KMT2B LRRC24 KAT6A KDM6B SRCAP MBD6 KIFC2 CASZ1 ITPR3 PRR12 ZGPAT TNRC18 LLGL2 BRD2 CTDP1 PXN MLLT6 ESPL1 AGRN PPP1R16A | 1.06e-10 | 1105 | 116 | 21 | 35748872 |
| Pubmed | 1.17e-10 | 4 | 116 | 4 | 23677673 | ||
| Pubmed | 5.86e-10 | 5 | 116 | 4 | 35061305 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCAPD3 MYBBP1A KMT2B ZC3H18 HMGA1 THOC2 TBC1D10B BRD2 CTDP1 MKI67 KDM2B GIGYF2 AFDN ESPL1 DHX29 PHF10 TP53BP1 | 8.89e-10 | 774 | 116 | 17 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCAPD3 MYBBP1A CEBPD KMT2B NOC2L POLR2E ZC3H18 HMGA1 SRCAP THOC2 CASZ1 ITPR3 PRR12 RCOR1 BRD2 NOM1 MKI67 KDM2B PDS5A MGA LCOR | 1.81e-09 | 1294 | 116 | 21 | 30804502 |
| Pubmed | 3.12e-09 | 157 | 116 | 9 | 30186101 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXE1 FOXO1 FOXO3 NCAPD3 NOC2L FRMPD1 POU2F2 HMGA1 CUL7 CASZ1 TWIST1 CRACD PRRC2C PDS5A FOXO4 MGA TP53BP1 | 4.07e-09 | 857 | 116 | 17 | 25609649 |
| Pubmed | MYBBP1A NOC2L ZC3H18 HMGA1 JARID2 ZGPAT RCOR1 BRD2 PRRC2C NOM1 PDS5A LCOR TP53BP1 | 6.45e-09 | 469 | 116 | 13 | 27634302 | |
| Pubmed | MYBBP1A KMT2B ACACB PSMD3 ZC3H18 CUL7 SRCAP MBD6 PRR12 RCOR1 BRD2 PRRC2C MKI67 KDM2B GIGYF2 PDS5A MLLT6 ZFHX3 MGA PHF10 TP53BP1 | 1.03e-08 | 1429 | 116 | 21 | 35140242 | |
| Pubmed | FOXO1 POU2F2 TWIST1 MEOX1 BRD2 IGHMBP2 MKI67 PXN AFDN FOXO4 ZFHX3 IRX2 PHF10 LCOR ZNF292 | 1.55e-08 | 709 | 116 | 15 | 22988430 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PCYT1A KMT2B KAT6A ZC3H18 ZNF362 SRCAP CASZ1 BRD2 MKI67 KDM2B PDS5A MLLT6 MGA ZNF292 | 1.69e-08 | 608 | 116 | 14 | 36089195 |
| Pubmed | NCAPD3 KMT2B NOC2L POLR2E TRIOBP CASZ1 PRR12 JARID2 CRACD ZGPAT BRD2 NOM1 IGHMBP2 PXN KDM2B PDS5A AFDN ZFHX3 DHX29 AGRN PPP1R12C | 2.29e-08 | 1497 | 116 | 21 | 31527615 | |
| Pubmed | 2.81e-08 | 202 | 116 | 9 | 24639526 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | KMT2B ACACB MBD6 PRR12 RCOR1 TNRC18 MKI67 KDM2B ZFHX3 MGA PHF10 | 2.89e-08 | 351 | 116 | 11 | 38297188 |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 25576059 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 27235148 | ||
| Pubmed | FoxO transcription factors 1 regulate mouse preimplantation embryo development. | 3.62e-08 | 3 | 116 | 3 | 31396850 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 25929834 | ||
| Pubmed | Functional regulation of FoxO1 in neural stem cell differentiation. | 3.62e-08 | 3 | 116 | 3 | 26470727 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 27491024 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 18272820 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 31767172 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 22102632 | ||
| Pubmed | Forkhead BoxO transcription factors restrain exercise-induced angiogenesis. | 3.62e-08 | 3 | 116 | 3 | 25063823 | |
| Pubmed | FOXOs attenuate bone formation by suppressing Wnt signaling. | 3.62e-08 | 3 | 116 | 3 | 23867625 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 18022395 | ||
| Pubmed | Forkhead box O transcription factors in chondrocytes regulate endochondral bone formation. | 3.62e-08 | 3 | 116 | 3 | 26232637 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 26917725 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 20142101 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 24015318 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 32847377 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 21613825 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 19671690 | ||
| Pubmed | FOXO transcription factors protect against the diet-induced fatty liver disease. | 3.62e-08 | 3 | 116 | 3 | 28300161 | |
| Pubmed | FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. | 3.62e-08 | 3 | 116 | 3 | 17254969 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 10880363 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 25307742 | ||
| Pubmed | Dysregulation of FOXO transcription factors in Epstein-Barr virus-associated gastric carcinoma. | 3.62e-08 | 3 | 116 | 3 | 31712122 | |
| Pubmed | Polymorphisms in FOXO gene family and association analysis with BMI. | 3.62e-08 | 3 | 116 | 3 | 16571842 | |
| Pubmed | FoxO transcription factors are required for hepatic HDL cholesterol clearance. | 3.62e-08 | 3 | 116 | 3 | 29408809 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 10783894 | ||
| Pubmed | The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors. | 3.62e-08 | 3 | 116 | 3 | 19244250 | |
| Pubmed | Expression of forkhead transcription factors in human granulosa cells. | 3.62e-08 | 3 | 116 | 3 | 18692812 | |
| Pubmed | Mitochondria Define Intestinal Stem Cell Differentiation Downstream of a FOXO/Notch Axis. | 3.62e-08 | 3 | 116 | 3 | 33147486 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 11875118 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 29178390 | ||
| Pubmed | FOXO responses to Porphyromonas gingivalis in epithelial cells. | 3.62e-08 | 3 | 116 | 3 | 25958948 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NCAPD3 MYBBP1A NOC2L POLR2E KAT6A PSMD3 CUL7 THOC2 PRRC2C NOM1 IGHMBP2 MCM9 MKI67 ESPL1 DHX29 | 3.79e-08 | 759 | 116 | 15 | 35915203 |
| Pubmed | FOXO1 FOXO3 POU2F2 HMGA1 SRCAP JARID2 ZGPAT BRD2 PXN MLLT6 ZFHX3 MGA PHF10 LCOR ZNF292 | 8.52e-08 | 808 | 116 | 15 | 20412781 | |
| Pubmed | FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. | 1.15e-07 | 14 | 116 | 4 | 19896444 | |
| Pubmed | FOXOs support the metabolic requirements of normal and tumor cells by promoting IDH1 expression. | 1.44e-07 | 4 | 116 | 3 | 25648147 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 25264246 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 11435445 | ||
| Pubmed | Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. | 1.44e-07 | 4 | 116 | 3 | 22197325 | |
| Pubmed | Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. | 1.44e-07 | 4 | 116 | 3 | 22147007 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 23835335 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 25858807 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 22411791 | ||
| Pubmed | FoxOs function synergistically to promote glucose production. | 1.44e-07 | 4 | 116 | 3 | 20880840 | |
| Pubmed | Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. | 1.44e-07 | 4 | 116 | 3 | 24040102 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 14978268 | ||
| Pubmed | FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation. | 1.44e-07 | 4 | 116 | 3 | 24781012 | |
| Pubmed | AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. | 1.44e-07 | 4 | 116 | 3 | 21884932 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 22405072 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 21510935 | ||
| Pubmed | Functional interaction between beta-catenin and FOXO in oxidative stress signaling. | 1.44e-07 | 4 | 116 | 3 | 15905404 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 27050511 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 21388966 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 16326148 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 12960271 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 30197237 | ||
| Pubmed | FOXO1/3 depletion in granulosa cells alters follicle growth, death and regulation of pituitary FSH. | 1.44e-07 | 4 | 116 | 3 | 23322722 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 31980519 | ||
| Pubmed | TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling. | 1.44e-07 | 4 | 116 | 3 | 18701653 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 22992773 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 29963746 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 29444976 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1A TRIOBP HMGA1 PRRC2C NOM1 MKI67 PXN GIGYF2 ESPL1 MGA DHX29 PHF10 LCOR ZNF292 | 1.45e-07 | 724 | 116 | 14 | 36232890 |
| Pubmed | MAP1A POLR2E KAT6A ZC3H18 ZNF362 CUL7 SRCAP TBC1D10B ZNF469 RCOR1 BRD2 ZFHX3 MGA IRX2 PHF10 LCOR WDTC1 | 1.85e-07 | 1116 | 116 | 17 | 31753913 | |
| Pubmed | Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy. | 3.60e-07 | 5 | 116 | 3 | 25516595 | |
| Pubmed | Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways. | 3.60e-07 | 5 | 116 | 3 | 12966085 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 22511764 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 34343133 | ||
| Pubmed | Liver sinusoidal endothelial cells link hyperinsulinemia to hepatic insulin resistance. | 3.60e-07 | 5 | 116 | 3 | 23349480 | |
| Pubmed | FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis. | 3.60e-07 | 5 | 116 | 3 | 21075312 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 30459233 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 25053419 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 23420833 | ||
| Pubmed | Loss of FoxOs in muscle increases strength and mitochondrial function during aging. | 3.60e-07 | 5 | 116 | 3 | 36442857 | |
| Pubmed | Sirtuin1 Suppresses Osteoclastogenesis by Deacetylating FoxOs. | 3.60e-07 | 5 | 116 | 3 | 26287518 | |
| Pubmed | Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis. | 3.60e-07 | 5 | 116 | 3 | 27525440 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 35185597 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 12192052 | ||
| Pubmed | Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification. | 3.60e-07 | 5 | 116 | 3 | 21653327 | |
| Pubmed | The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress. | 3.60e-07 | 5 | 116 | 3 | 23851496 | |
| Pubmed | 6.73e-07 | 21 | 116 | 4 | 21571225 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MYBBP1A ZC3H18 ZNF362 HMGA1 THOC2 BRD2 PRRC2C MKI67 GIGYF2 PDS5A AFDN MLLT6 MGA LCOR TP53BP1 | 7.02e-07 | 954 | 116 | 15 | 36373674 |
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 24570486 | ||
| Pubmed | Selective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling. | 7.18e-07 | 6 | 116 | 3 | 29056338 | |
| Pubmed | FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf. | 7.18e-07 | 6 | 116 | 3 | 17974917 | |
| Interaction | H2BC21 interactions | KMT2B NOC2L POLR2E KAT6A CC2D1B ZC3H18 HMGA1 CUL7 KDM6B SRCAP PRR12 RCOR1 CCDC71 BRD2 MKI67 PHF10 LCOR CDK5R2 ZNF292 WDTC1 | 1.47e-09 | 696 | 112 | 20 | int:H2BC21 |
| Interaction | H3C1 interactions | MYBBP1A KMT2B KAT6A PSMD3 HMGA1 KDM6B SRCAP THBS1 RCOR1 TNRC18 BRD2 PRRC2C MKI67 PXN KDM2B PDS5A TSPYL5 ZFHX3 MGA LCOR TP53BP1 ZNF292 | 4.07e-09 | 901 | 112 | 22 | int:H3C1 |
| Interaction | HMGA1 interactions | FOXE1 GPC1 ACACB KAT6A POU2F2 ZC3H18 HMGA1 CUL7 SRCAP RCOR1 TNRC18 CCDC71 PHF10 LCOR AGRN | 1.14e-08 | 419 | 112 | 15 | int:HMGA1 |
| Interaction | POLR1G interactions | FOXO1 MYBBP1A KMT2B NOC2L POLR2E KAT6A ZC3H18 ZNF362 SRCAP BRD2 KDM2B PDS5A MGA LCOR ZNF292 | 8.72e-08 | 489 | 112 | 15 | int:POLR1G |
| Interaction | CENPA interactions | PCYT1A KMT2B KAT6A ZNF362 HMGA1 THOC2 CASZ1 BRD2 KDM2B PDS5A MLLT6 LCOR ZNF292 | 1.79e-07 | 377 | 112 | 13 | int:CENPA |
| Interaction | POLR1E interactions | MYBBP1A NOC2L POLR2E SRCAP CASZ1 BRD2 NOM1 KDM2B MLLT6 MGA LCOR ZNF292 | 5.81e-07 | 350 | 112 | 12 | int:POLR1E |
| Interaction | H3-3A interactions | PCYT1A KMT2B KAT6A ZNF362 HMGA1 KDM6B SRCAP CASZ1 CCDC71 BRD2 MKI67 KDM2B PDS5A TSPYL5 MLLT6 MGA ZNF292 | 8.13e-07 | 749 | 112 | 17 | int:H3-3A |
| Interaction | ZNF330 interactions | MYBBP1A KMT2B NOC2L RSPO4 ZC3H18 ZNF362 HMGA1 BRD2 KDM2B PDS5A MLLT6 LCOR ZNF292 | 1.19e-06 | 446 | 112 | 13 | int:ZNF330 |
| Interaction | ASF1A interactions | 1.30e-06 | 249 | 112 | 10 | int:ASF1A | |
| Interaction | TOP3B interactions | FOXO3 KMT2B LRRC24 NOC2L KAT6A KDM6B SRCAP MBD6 THOC2 KIFC2 CASZ1 ITPR3 PRR12 ZGPAT TNRC18 LLGL2 BRD2 CTDP1 PXN MLLT6 ESPL1 AGRN TP53BP1 PPP1R16A | 1.41e-06 | 1470 | 112 | 24 | int:TOP3B |
| Interaction | APEX1 interactions | KMT2B NOC2L KAT6A ZNF362 HMGA1 SRCAP THOC2 CASZ1 ZGPAT TBC1D10B BRD2 UNC5C CTDP1 GIGYF2 PDS5A MGA DHX29 BAIAP3 PHF10 LCOR TP53BP1 ZNF292 | 1.63e-06 | 1271 | 112 | 22 | int:APEX1 |
| Interaction | TERF2IP interactions | PCYT1A KMT2B ZC3H18 ZNF362 SRCAP THOC2 ZGPAT RCOR1 MKI67 KDM2B PDS5A MGA PHF10 ZNF292 | 2.32e-06 | 552 | 112 | 14 | int:TERF2IP |
| Interaction | CBX3 interactions | KMT2B ZNF362 HMGA1 CUL7 KDM6B CCDC71 BRD2 MKI67 KDM2B PDS5A MGA PHF10 LCOR TP53BP1 ZNF292 | 2.91e-06 | 646 | 112 | 15 | int:CBX3 |
| Interaction | POU5F1 interactions | NCAPD3 ACACB PSMD3 HMGA1 ITPR3 JARID2 ZGPAT KDM2B GIGYF2 AFDN ZFHX3 MGA DHX29 TP53BP1 | 4.46e-06 | 584 | 112 | 14 | int:POU5F1 |
| Interaction | L3MBTL2 interactions | 5.77e-06 | 231 | 112 | 9 | int:L3MBTL2 | |
| Interaction | MYB interactions | 9.48e-06 | 133 | 112 | 7 | int:MYB | |
| Interaction | WDR5 interactions | MYBBP1A KMT2B ACACB KAT6A PSMD3 ZC3H18 HMGA1 KDM6B MBD6 TWIST1 ITPR3 ZGPAT THBS1 PRRC2C KDM2B GIGYF2 AFDN MGA WDTC1 | 9.75e-06 | 1101 | 112 | 19 | int:WDR5 |
| Interaction | NUMA1 interactions | FOXO1 KAT6A ZC3H18 HMGA1 CUL7 SRCAP RCOR1 BRD2 MKI67 PHF10 LCOR TP53BP1 | 1.18e-05 | 469 | 112 | 12 | int:NUMA1 |
| Interaction | HP1BP3 interactions | 1.52e-05 | 329 | 112 | 10 | int:HP1BP3 | |
| Interaction | LGR4 interactions | 1.58e-05 | 262 | 112 | 9 | int:LGR4 | |
| Interaction | ASH2L interactions | 1.73e-05 | 265 | 112 | 9 | int:ASH2L | |
| Interaction | H2BC8 interactions | PCYT1A KMT2B ZNF362 HMGA1 SRCAP RCOR1 BRD2 MKI67 KDM2B PDS5A MGA PHF10 ZNF292 | 1.90e-05 | 576 | 112 | 13 | int:H2BC8 |
| Interaction | PSIP1 interactions | 1.92e-05 | 205 | 112 | 8 | int:PSIP1 | |
| Interaction | H3C3 interactions | PCYT1A KMT2B ZC3H18 ZNF362 SRCAP BRD2 MKI67 KDM2B PDS5A MLLT6 MGA ZNF292 | 2.01e-05 | 495 | 112 | 12 | int:H3C3 |
| Interaction | PCGF1 interactions | 2.14e-05 | 208 | 112 | 8 | int:PCGF1 | |
| Interaction | DEK interactions | 2.21e-05 | 209 | 112 | 8 | int:DEK | |
| Interaction | BGN interactions | 2.22e-05 | 30 | 112 | 4 | int:BGN | |
| Interaction | RBBP7 interactions | ACACB PSMD3 ZC3H18 HMGA1 TWIST1 JARID2 ZGPAT RCOR1 TNRC18 CCDC71 LCOR WDTC1 | 2.55e-05 | 507 | 112 | 12 | int:RBBP7 |
| Interaction | NPM1 interactions | GPC1 BDP1 MYBBP1A NOC2L POLR2E KAT6A ZC3H18 HMGA1 CUL7 MBD6 THOC2 RCOR1 PRRC2C NOM1 UNC5C MKI67 DHX29 AGRN WDTC1 | 3.26e-05 | 1201 | 112 | 19 | int:NPM1 |
| Interaction | AR interactions | FOXO1 MYBBP1A POU2F2 PSMD3 ZNF362 SRCAP CASZ1 PRR12 RCOR1 TNRC18 BRD2 PXN KDM2B PDS5A ZFHX3 MGA LCOR | 3.32e-05 | 992 | 112 | 17 | int:AR |
| Interaction | CBX1 interactions | 3.33e-05 | 288 | 112 | 9 | int:CBX1 | |
| Interaction | JPH4 interactions | 3.82e-05 | 68 | 112 | 5 | int:JPH4 | |
| Interaction | SMAD3 interactions | FOXO1 FOXO3 CEBPD KMT2B ALKBH2 KAT6A KDM6B FOXO4 ZFHX3 PPP1R12C JPH3 | 3.97e-05 | 447 | 112 | 11 | int:SMAD3 |
| Interaction | NFIX interactions | 3.98e-05 | 227 | 112 | 8 | int:NFIX | |
| Interaction | NUP43 interactions | KMT2B ACACB NOC2L ZC3H18 CUL7 SRCAP PRRC2C MKI67 MLLT6 ZFHX3 MGA LCOR ZNF292 | 4.42e-05 | 625 | 112 | 13 | int:NUP43 |
| Interaction | CSNK2A2 interactions | POLR2E KAT6A ZC3H18 HMGA1 RCOR1 BRD2 PRRC2C CTDP1 MKI67 KDM2B PDS5A MGA TP53BP1 WDTC1 | 4.46e-05 | 718 | 112 | 14 | int:CSNK2A2 |
| Interaction | SPEN interactions | 6.19e-05 | 178 | 112 | 7 | int:SPEN | |
| Interaction | HDAC4 interactions | GPC1 MYBBP1A CEBPD CUL7 LMTK3 PRR12 TBC1D10B THBS1 PRRC2C GIGYF2 DHX29 PHF10 LCOR TP53BP1 | 6.54e-05 | 744 | 112 | 14 | int:HDAC4 |
| Interaction | NANOG interactions | NCAPD3 MYBBP1A KMT2B ACACB HMGA1 ITPR3 JARID2 ZGPAT KDM2B MGA TP53BP1 | 7.67e-05 | 481 | 112 | 11 | int:NANOG |
| Interaction | MECP2 interactions | FOXE1 MYBBP1A MAP1A NOC2L TRIOBP ZC3H18 HMGA1 LMTK3 SRCAP THOC2 TBC1D10B RCOR1 BRD2 MKI67 PDS5A TSPYL5 AGRN TP53BP1 ZNF292 | 8.28e-05 | 1287 | 112 | 19 | int:MECP2 |
| Interaction | H1-0 interactions | 9.26e-05 | 256 | 112 | 8 | int:H1-0 | |
| Interaction | HNF1B interactions | 9.33e-05 | 190 | 112 | 7 | int:HNF1B | |
| Interaction | SOX7 interactions | 9.41e-05 | 82 | 112 | 5 | int:SOX7 | |
| Interaction | RCOR1 interactions | KMT2B ACACB HMGA1 RCOR1 LLGL2 MKI67 KDM2B GIGYF2 ZFHX3 MGA TP53BP1 | 9.71e-05 | 494 | 112 | 11 | int:RCOR1 |
| Interaction | FOXO6 interactions | 1.07e-04 | 17 | 112 | 3 | int:FOXO6 | |
| Interaction | PARP1 interactions | FOXO1 NOC2L ZC3H18 ZNF362 HMGA1 CUL7 SRCAP MBD6 CASZ1 BRD2 MKI67 KDM2B PDS5A MLLT6 MGA PHF10 AGRN TP53BP1 ZNF292 | 1.11e-04 | 1316 | 112 | 19 | int:PARP1 |
| Interaction | MAU2 interactions | 1.13e-04 | 136 | 112 | 6 | int:MAU2 | |
| Interaction | EED interactions | NCAPD3 MYBBP1A ACACB NOC2L PSMD3 HMGA1 CUL7 THOC2 CASZ1 JARID2 CCDC71 NOM1 KDM2B PDS5A AFDN MGA LCOR AGRN TP53BP1 WDTC1 | 1.27e-04 | 1445 | 112 | 20 | int:EED |
| Interaction | PHF21A interactions | 1.27e-04 | 343 | 112 | 9 | int:PHF21A | |
| Interaction | HDAC1 interactions | MYBBP1A CEBPD KMT2B ACACB CASZ1 XYLT2 ZGPAT RCOR1 TNRC18 CCDC71 MKI67 PXN KDM2B GIGYF2 ZFHX3 MGA LCOR | 1.29e-04 | 1108 | 112 | 17 | int:HDAC1 |
| Interaction | PPP1CA interactions | NOC2L POLR2E TRIOBP ZC3H18 CUL7 SH3RF2 NOM1 CTDP1 MKI67 DYNLT4 PPP1R12C JPH3 PPP1R16A | 1.30e-04 | 696 | 112 | 13 | int:PPP1CA |
| Interaction | CFH interactions | 1.32e-04 | 140 | 112 | 6 | int:CFH | |
| Interaction | OBSL1 interactions | MYBBP1A NOC2L POLR2E PSMD3 HMGA1 CUL7 SRCAP THOC2 TWIST1 ITPR3 BRD2 MKI67 AFDN MGA DHX29 | 1.40e-04 | 902 | 112 | 15 | int:OBSL1 |
| Interaction | HNF4A interactions | 1.52e-04 | 275 | 112 | 8 | int:HNF4A | |
| Interaction | PYHIN1 interactions | 1.75e-04 | 358 | 112 | 9 | int:PYHIN1 | |
| Interaction | EZHIP interactions | 1.78e-04 | 20 | 112 | 3 | int:EZHIP | |
| Interaction | MACROH2A2 interactions | 1.79e-04 | 211 | 112 | 7 | int:MACROH2A2 | |
| Interaction | FOXG1 interactions | 1.89e-04 | 95 | 112 | 5 | int:FOXG1 | |
| Interaction | XRCC6 interactions | MYBBP1A POU2F2 PSMD3 ZC3H18 ZNF362 HMGA1 CUL7 MBD6 THOC2 TNRC18 MKI67 ZFHX3 USP35 MGA TP53BP1 | 1.91e-04 | 928 | 112 | 15 | int:XRCC6 |
| Interaction | NEIL2 interactions | 2.07e-04 | 21 | 112 | 3 | int:NEIL2 | |
| Interaction | PHC2 interactions | 2.14e-04 | 153 | 112 | 6 | int:PHC2 | |
| Interaction | CHD4 interactions | FOXE1 MYBBP1A NOC2L KAT6A ZC3H18 HMGA1 CUL7 TWIST1 RCOR1 BRD2 PRRC2C NOM1 MKI67 GIGYF2 ZFHX3 | 2.15e-04 | 938 | 112 | 15 | int:CHD4 |
| Interaction | BRD7 interactions | FOXO1 NCAPD3 MYBBP1A HMGA1 THOC2 TWIST1 BRD2 PRRC2C NOM1 IGHMBP2 MKI67 PHF10 | 2.22e-04 | 637 | 112 | 12 | int:BRD7 |
| Interaction | SNRNP40 interactions | KMT2B ACACB KAT6A ZC3H18 ZNF362 CUL7 ZGPAT MKI67 MLLT6 ZFHX3 MGA PHF10 | 2.22e-04 | 637 | 112 | 12 | int:SNRNP40 |
| Interaction | PPP1CC interactions | MYBBP1A SPAG1 POLR2E TRIOBP ZC3H18 CUL7 TWIST1 PRR12 SH3RF2 MKI67 DYNLT4 PPP1R12C PPP1R16A | 2.32e-04 | 738 | 112 | 13 | int:PPP1CC |
| Interaction | LYAR interactions | 2.38e-04 | 373 | 112 | 9 | int:LYAR | |
| Interaction | SIRT7 interactions | FOXO1 MYBBP1A NOC2L ZC3H18 CUL7 THOC2 ITPR3 PRRC2C MKI67 GIGYF2 PDS5A AFDN TP53BP1 | 2.51e-04 | 744 | 112 | 13 | int:SIRT7 |
| Interaction | COIL interactions | NOC2L ZC3H18 ZNF362 CASZ1 BRD2 MKI67 KDM2B PDS5A MLLT6 MGA ZNF292 | 2.55e-04 | 552 | 112 | 11 | int:COIL |
| Interaction | SMARCA4 interactions | FOXE1 FOXO1 MYBBP1A KAT6A HMGA1 KDM6B SRCAP RCOR1 BRD2 PHF10 | 2.56e-04 | 462 | 112 | 10 | int:SMARCA4 |
| Interaction | CSNK2A1 interactions | BDP1 KMT2B POLR2E KAT6A ZC3H18 HMGA1 CUL7 MEOX1 RCOR1 LLGL2 BRD2 PRRC2C CTDP1 KDM2B MGA | 2.63e-04 | 956 | 112 | 15 | int:CSNK2A1 |
| Interaction | RIF1 interactions | 2.64e-04 | 225 | 112 | 7 | int:RIF1 | |
| Interaction | C1D interactions | 2.66e-04 | 56 | 112 | 4 | int:C1D | |
| Interaction | DDX56 interactions | 2.99e-04 | 304 | 112 | 8 | int:DDX56 | |
| Interaction | RB1CC1 interactions | 3.12e-04 | 387 | 112 | 9 | int:RB1CC1 | |
| Interaction | TAF10 interactions | 3.28e-04 | 107 | 112 | 5 | int:TAF10 | |
| Interaction | RBBP4 interactions | ACACB PSMD3 ZC3H18 HMGA1 CUL7 JARID2 RCOR1 TNRC18 CCDC71 KDM2B LCOR | 3.50e-04 | 573 | 112 | 11 | int:RBBP4 |
| Interaction | HECTD1 interactions | NCAPD3 MYBBP1A NOC2L POLR2E KAT6A PSMD3 CUL7 THOC2 PRRC2C NOM1 IGHMBP2 MCM9 MKI67 ESPL1 DHX29 | 3.58e-04 | 984 | 112 | 15 | int:HECTD1 |
| Interaction | RUVBL1 interactions | POLR2E PSMD3 ZC3H18 CUL7 SRCAP RCOR1 IGHMBP2 MCM9 ARHGEF26 MGA TP53BP1 | 3.60e-04 | 575 | 112 | 11 | int:RUVBL1 |
| Interaction | EGR2 interactions | 3.89e-04 | 171 | 112 | 6 | int:EGR2 | |
| Interaction | MGA interactions | 3.90e-04 | 240 | 112 | 7 | int:MGA | |
| Interaction | RPL7A interactions | GPC1 MYBBP1A NOC2L KAT6A ZC3H18 CUL7 H1-8 TNRC18 CFAP77 NOM1 GIGYF2 DHX29 | 3.96e-04 | 679 | 112 | 12 | int:RPL7A |
| Interaction | USP24 interactions | 4.05e-04 | 112 | 112 | 5 | int:USP24 | |
| Interaction | LCOR interactions | 4.10e-04 | 242 | 112 | 7 | int:LCOR | |
| Interaction | SMC5 interactions | MYBBP1A ZC3H18 ZNF362 HMGA1 THOC2 BRD2 PRRC2C MKI67 GIGYF2 PDS5A AFDN MLLT6 MGA LCOR TP53BP1 | 4.24e-04 | 1000 | 112 | 15 | int:SMC5 |
| Interaction | H2BC3 interactions | 4.42e-04 | 406 | 112 | 9 | int:H2BC3 | |
| Interaction | WHRN interactions | 4.43e-04 | 27 | 112 | 3 | int:WHRN | |
| Interaction | FOXO3B interactions | 4.53e-04 | 6 | 112 | 2 | int:FOXO3B | |
| Interaction | EBNA1BP2 interactions | 4.57e-04 | 324 | 112 | 8 | int:EBNA1BP2 | |
| Interaction | ELF4 interactions | 4.58e-04 | 115 | 112 | 5 | int:ELF4 | |
| Interaction | CEBPA interactions | NCAPD3 CEBPD KMT2B NOC2L ZNF362 HMGA1 THOC2 PRR12 RCOR1 TNRC18 PRRC2C MKI67 PDS5A MLLT6 LCOR TP53BP1 ZNF292 | 5.06e-04 | 1245 | 112 | 17 | int:CEBPA |
| Interaction | CAMKV interactions | 5.15e-04 | 118 | 112 | 5 | int:CAMKV | |
| Interaction | SMARCA5 interactions | 5.18e-04 | 415 | 112 | 9 | int:SMARCA5 | |
| Interaction | H2BC5 interactions | 5.27e-04 | 331 | 112 | 8 | int:H2BC5 | |
| Interaction | CRX interactions | 5.48e-04 | 254 | 112 | 7 | int:CRX | |
| Interaction | MEN1 interactions | NCAPD3 MYBBP1A KMT2B NOC2L POLR2E ZC3H18 SRCAP THOC2 PRR12 NOM1 MKI67 GIGYF2 PDS5A AFDN TP53BP1 | 5.71e-04 | 1029 | 112 | 15 | int:MEN1 |
| Interaction | EXOSC6 interactions | 5.77e-04 | 121 | 112 | 5 | int:EXOSC6 | |
| Interaction | FTSJ3 interactions | 5.84e-04 | 422 | 112 | 9 | int:FTSJ3 | |
| Interaction | FGFBP1 interactions | 5.87e-04 | 257 | 112 | 7 | int:FGFBP1 | |
| Interaction | PES1 interactions | 6.01e-04 | 258 | 112 | 7 | int:PES1 | |
| Interaction | DDX47 interactions | 6.07e-04 | 186 | 112 | 6 | int:DDX47 | |
| Cytoband | 8q24.3 | 2.01e-04 | 113 | 116 | 4 | 8q24.3 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.80e-06 | 181 | 83 | 8 | 694 | |
| GeneFamily | Forkhead boxes | 4.45e-05 | 43 | 83 | 4 | 508 | |
| GeneFamily | PHD finger proteins | 5.84e-05 | 90 | 83 | 5 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.99e-04 | 25 | 83 | 3 | 775 | |
| GeneFamily | Paraneoplastic Ma antigens | 1.11e-03 | 11 | 83 | 2 | 671 | |
| GeneFamily | Zinc fingers CXXC-type | 1.33e-03 | 12 | 83 | 2 | 136 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 3.65e-06 | 145 | 115 | 7 | M1810 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 | GPC1 LRRC24 HMGA1 CUL7 LMTK3 KDM6B MBD6 PRR12 JARID2 CRACD MCM9 KDM2B MLLT6 ZFHX3 RSPO1 LCOR AGRN CCS WDTC1 | 3.63e-05 | 1275 | 112 | 19 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | FOXO3 PCYT1A KDM6B SRCAP THOC2 PNMA8B SYT16 THBS1 BRD2 PRRC2C GIGYF2 MGA RSPO1 LCOR | 6.05e-05 | 778 | 112 | 14 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | KDM6B SRCAP THOC2 RUFY3 PNMA8B TNRC18 TRPM5 BRD2 PRRC2C GIGYF2 COL14A1 MGA RSPO1 LCOR | 7.12e-05 | 790 | 112 | 14 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | KDM6B SRCAP THOC2 RUFY3 PNMA8B TNRC18 TRPM5 BRD2 PRRC2C GIGYF2 ZFHX3 MGA RSPO1 LCOR | 8.25e-05 | 801 | 112 | 14 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-08 | 189 | 116 | 8 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.56e-07 | 200 | 116 | 7 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-06 | 174 | 116 | 6 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-06 | 179 | 116 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-06 | 181 | 116 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-06 | 186 | 116 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 9.37e-06 | 186 | 116 | 6 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.38e-05 | 199 | 116 | 6 | f8846446ebbc4948cdc69640782db1358bbdc486 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.38e-05 | 199 | 116 | 6 | fe9f5bc317be0c35bd96311bf0b3c7b91d98acc5 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.38e-05 | 199 | 116 | 6 | 3e35ee426ef06f9af568c37349b62dd1ee9b97ea | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.41e-05 | 200 | 116 | 6 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-05 | 200 | 116 | 6 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.41e-05 | 200 | 116 | 6 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 1.99e-05 | 126 | 116 | 5 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-05 | 163 | 116 | 5 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.42e-05 | 166 | 116 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 7.85e-05 | 168 | 116 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.07e-05 | 169 | 116 | 5 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.26e-05 | 174 | 116 | 5 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.06e-04 | 179 | 116 | 5 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 182 | 116 | 5 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.17e-04 | 183 | 116 | 5 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | IPF-Epithelial-ATI|IPF / Disease state, Lineage and Cell class | 1.17e-04 | 183 | 116 | 5 | c0a3541c45bd0c587603521f392f42dd86c3c35b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 184 | 116 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 184 | 116 | 5 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 184 | 116 | 5 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 184 | 116 | 5 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 184 | 116 | 5 | b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 185 | 116 | 5 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 185 | 116 | 5 | ef996f4cdbc3971c6c0460d13df64b075ab22154 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 185 | 116 | 5 | d51342a3979bd728a80e04126059a3fd8a0dbe3b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 185 | 116 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 185 | 116 | 5 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 185 | 116 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 186 | 116 | 5 | a66da8453bb78f7e9f5f59452b3c50ae679d83c3 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 1.30e-04 | 187 | 116 | 5 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.33e-04 | 188 | 116 | 5 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.33e-04 | 188 | 116 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 189 | 116 | 5 | fccadf8efbef17b7f12291b069c71060a71b04e2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 116 | 5 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.43e-04 | 191 | 116 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 116 | 5 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.47e-04 | 192 | 116 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.50e-04 | 193 | 116 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 194 | 116 | 5 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 194 | 116 | 5 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | 18-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 1.54e-04 | 194 | 116 | 5 | 9a2efa50731135a178141aae55fa8b3e022c9904 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-04 | 195 | 116 | 5 | ae98215b7b7f22f1aca690920ce6092dc4a3c7db | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-04 | 195 | 116 | 5 | 6fcab7aa4db958ccad0300adea9aaae52ace5bff | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 195 | 116 | 5 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 195 | 116 | 5 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 1.58e-04 | 195 | 116 | 5 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-04 | 196 | 116 | 5 | 547901c7a665770eff78eede69b8625b416c8186 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 196 | 116 | 5 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 196 | 116 | 5 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.62e-04 | 196 | 116 | 5 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-04 | 196 | 116 | 5 | 6e08d7ba67da161c2dca1a17c440ffb9d9b5bc3b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 197 | 116 | 5 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.66e-04 | 197 | 116 | 5 | b7aff83c27606d87565382a768119a863fe1c294 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.69e-04 | 198 | 116 | 5 | dcf334d13e5b0018fee24febccfef91c9e17843b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 198 | 116 | 5 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.73e-04 | 199 | 116 | 5 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.78e-04 | 200 | 116 | 5 | c6f211bbadd0c9be776c58807249e06764df47dc | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-04 | 200 | 116 | 5 | 50b8788494b744e0f0ec8c4d67a1c90ae09dca65 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Transitional_AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.78e-04 | 200 | 116 | 5 | 1ba6327851aa61e9a1f1fe1671bc27929d93ac74 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-04 | 200 | 116 | 5 | f5f24273bee3259a4a3be99ba53b88defa1286c0 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 200 | 116 | 5 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 200 | 116 | 5 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 200 | 116 | 5 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.78e-04 | 200 | 116 | 5 | 5f7e8d8b05c90a10313775f9f126eb4ab0fe4f67 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Intermediate|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.78e-04 | 200 | 116 | 5 | e5a8647c47a49c8c90c78d681193946de103d8ff | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.78e-04 | 200 | 116 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.78e-04 | 200 | 116 | 5 | e3a80626941363bfc9d97ef906d38c97080aecb1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.78e-04 | 200 | 116 | 5 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| Drug | Gliquidone [33342-05-1]; Up 200; 7.6uM; HL60; HT_HG-U133A | 5.47e-07 | 194 | 113 | 9 | 3126_UP | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 5.73e-06 | 194 | 113 | 8 | 3861_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 5.95e-06 | 195 | 113 | 8 | 4199_DN | |
| Drug | Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 6.42e-06 | 197 | 113 | 8 | 5463_UP | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; PC3; HT_HG-U133A | 6.66e-06 | 198 | 113 | 8 | 4193_DN | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 4.47e-05 | 189 | 113 | 7 | 7206_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 5.11e-05 | 193 | 113 | 7 | 3262_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | 5.28e-05 | 194 | 113 | 7 | 4242_DN | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; HL60; HT_HG-U133A | 5.45e-05 | 195 | 113 | 7 | 2425_UP | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 5.45e-05 | 195 | 113 | 7 | 6614_DN | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; HL60; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 3098_UP | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 6041_UP | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 3133_DN | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 6078_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; HL60; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 3112_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 2226_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 5283_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; HL60; HG-U133A | 6.20e-05 | 199 | 113 | 7 | 1415_UP | |
| Drug | Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; HL60; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 3059_DN | |
| Disease | Adenoid Cystic Carcinoma | 2.21e-06 | 100 | 111 | 6 | C0010606 | |
| Disease | factor VIII measurement, Ischemic stroke | 4.80e-05 | 19 | 111 | 3 | EFO_0004630, HP_0002140 | |
| Disease | Prostatic Neoplasms | FOXO1 MYBBP1A SELENOS KAT6A COL5A3 CASZ1 PDS5A ZFHX3 MGA ZNF292 | 1.14e-04 | 616 | 111 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | FOXO1 MYBBP1A SELENOS KAT6A COL5A3 CASZ1 PDS5A ZFHX3 MGA ZNF292 | 1.14e-04 | 616 | 111 | 10 | C0376358 |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 1.43e-03 | 15 | 111 | 2 | EFO_0004791, HP_0002140 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 1.63e-03 | 16 | 111 | 2 | EFO_0004792, HP_0002140 | |
| Disease | sphingomyelin 14:0 measurement | 1.84e-03 | 17 | 111 | 2 | EFO_0010390 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.84e-03 | 17 | 111 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | factor XI measurement, Ischemic stroke | 1.84e-03 | 17 | 111 | 2 | EFO_0004694, HP_0002140 | |
| Disease | breast carcinoma (is_marker_for) | 2.00e-03 | 66 | 111 | 3 | DOID:3459 (is_marker_for) | |
| Disease | stroke | 2.18e-03 | 144 | 111 | 4 | EFO_0000712 | |
| Disease | neutrophil percentage of leukocytes | 2.18e-03 | 610 | 111 | 8 | EFO_0007990 | |
| Disease | corneal hysteresis | 2.55e-03 | 20 | 111 | 2 | EFO_0010066 | |
| Disease | Non-Small Cell Lung Carcinoma | 2.90e-03 | 156 | 111 | 4 | C0007131 | |
| Disease | Leber Congenital Amaurosis | 3.08e-03 | 22 | 111 | 2 | C0339527 | |
| Disease | Hepatitis, Chronic | 3.08e-03 | 22 | 111 | 2 | C0019189 | |
| Disease | Chronic active hepatitis | 3.08e-03 | 22 | 111 | 2 | C0520463 | |
| Disease | Cryptogenic Chronic Hepatitis | 3.08e-03 | 22 | 111 | 2 | C0524611 | |
| Disease | Chronic Persistent Hepatitis | 3.08e-03 | 22 | 111 | 2 | C0149519 | |
| Disease | granulocyte percentage of myeloid white cells | 3.49e-03 | 268 | 111 | 5 | EFO_0007997 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EREKPGPGQRKRGAH | 71 | A8MU10 | |
| STRKRPRREAPGNGG | 36 | Q6NS38 | |
| RRGSGKPRPKSEGFE | 1116 | P55196 | |
| KRGRQKPKAAPEGAG | 481 | Q9Y5B0 | |
| GGRGPRGHKRKLNEE | 911 | Q9Y5B0 | |
| SKRSRHGPGRPKGSR | 471 | P55198 | |
| FQKPKPNIGRGTGRR | 811 | A6H8Y1 | |
| IKGGPQAELGKPRER | 96 | Q6ZQR2 | |
| RFGFRKGSKRGGPLP | 241 | O94812 | |
| GRPSKYDVRGIQKPG | 371 | Q86V15 | |
| GDGPRVLGESPKSRK | 1741 | O00468 | |
| SGRKAKDPERGLFPG | 191 | Q96DR7 | |
| AAAGSREPRVKQGPK | 51 | Q7Z478 | |
| SSAKGRRPGGLPEEK | 11 | Q13319 | |
| GAAGALPAQRTKRKP | 81 | O95158 | |
| EKGPEVSGKRRGRNN | 6 | Q9UKL0 | |
| SKPRRGRRPKSESQG | 1266 | Q29RF7 | |
| EPPSAAAKGRKAKRG | 151 | Q9Y4B5 | |
| PGVPAGAKRNRKTNG | 26 | H3BPF8 | |
| RNGGGVGDILRKPSK | 2471 | Q14573 | |
| ARRRPNSGPAGGSKE | 101 | P50221 | |
| PASHKGPKDAGRRRN | 76 | O00763 | |
| RGINGEARPARGRKP | 866 | Q96DN6 | |
| APATAPRRAGEAKGK | 141 | Q8IZA3 | |
| VQGRVGRRAPGKAKP | 2601 | P78559 | |
| GRRAPGKAKPASPAR | 2606 | P78559 | |
| RLDLRGKRSPTPGKG | 2621 | P78559 | |
| PGTGKERLKAGASPR | 76 | Q96MG2 | |
| GNGAGPKKAPSRARN | 946 | Q6P1M3 | |
| ASPNVPGKRGRPRKL | 606 | Q8IWI9 | |
| PKGGERRQAAPGRFA | 1101 | Q9UKN7 | |
| AKDSGRKPSPVRPRG | 16 | Q5JR98 | |
| QGPGPEEKRRRGKLA | 351 | P35052 | |
| RNYGAKRGGPPVKRA | 186 | O15054 | |
| GPRKAGRGPGNREKV | 886 | Q96Q04 | |
| ARKRRKEAPGPNGAT | 11 | P49585 | |
| NPEGGKSGKAPRRRA | 181 | P98177 | |
| EGDPGSKQPRKKRGR | 331 | Q96JN0 | |
| PGGVLKIRDGSKEPR | 1521 | Q14999 | |
| PSLGFDGLPGRRRKK | 286 | P09086 | |
| RRKKARGPPGEGALF | 431 | Q50LG9 | |
| GRAPRGRGRKHKTTP | 146 | Q9UMN6 | |
| TEVPKRGGRKSGNLP | 611 | P46013 | |
| DKPGGSPSASRRKGR | 51 | Q9Y3T9 | |
| EAAPRGGRKTPQGSR | 301 | Q9BZI1 | |
| GGSQPPSMGRKKRNR | 1201 | Q9BQG0 | |
| KPKRNGGRGLEDVRP | 201 | P49023 | |
| APPTPRKVGRRGKNS | 481 | Q8WUB8 | |
| GPFSKVRTGPGRGRK | 351 | Q92794 | |
| RGLGDRPKPRAKEGT | 126 | Q8NC74 | |
| QEHGQGPPRKRKRAS | 606 | Q8NC74 | |
| ARTQPRGRGRPKGSA | 356 | Q8IV32 | |
| PGNPGLNGRSRRAKK | 1446 | Q14674 | |
| PEGGKSGKSPRRRAA | 241 | Q12778 | |
| TPKNRAVGRPKGKLG | 576 | Q8NHM5 | |
| KPGRKDVGRPNFEEG | 171 | Q6Y7W6 | |
| PAREKSAGKRGPDRG | 176 | P49716 | |
| PKPRVKVVDRGNGSR | 126 | Q05707 | |
| GPDGRQPSRRGGVKK | 816 | Q5SYB0 | |
| GPGDARAGSGKAKPR | 641 | Q6ZU35 | |
| RPRKGPQARGQGVAA | 6 | Q5T0F9 | |
| GRPIAGKGRKESAQP | 256 | O14618 | |
| ARPGSSRKVPGAQKR | 126 | K9M1U5 | |
| QGEPETPRPRRKGKG | 236 | P25940 | |
| SERARKAGAAGPPRG | 631 | Q96AC6 | |
| RPRGRPKGSKNKGAA | 56 | P17096 | |
| RNRPKRATAGKSTPG | 496 | Q92833 | |
| SKSPPPERKNRGERG | 1071 | Q9NXL9 | |
| INPDGGKSGKAPRRR | 236 | O43524 | |
| KDLPGLKTPVGRGRA | 151 | Q7L099 | |
| RASGPPAKAKEAGKR | 6 | Q9H321 | |
| GPGPQAAREHRKVGK | 616 | Q9BZL4 | |
| KAQSGDKPSEGRPRR | 41 | P19388 | |
| CPGERSPGQKKGRKD | 196 | Q2I0M5 | |
| PGKKHRGRTNIQRGP | 396 | Q17RD7 | |
| FLKIPREAGRPGKGN | 111 | O00358 | |
| KGKKRSRGGRPSAPA | 176 | Q9ULN7 | |
| GRGRGVTPEKKAGSR | 566 | Q9ULN7 | |
| RNERRSGPPSKSGKR | 1571 | Q9Y520 | |
| GKKGPGERPRKEAAS | 46 | Q96I34 | |
| CPEGQKRRKGGQGRR | 206 | Q2MKA7 | |
| GRKPRSPRDSGPQKE | 26 | Q96M53 | |
| QPKPASLGRGRGAAA | 91 | Q8IVW8 | |
| RRGPAGGGEKALKRL | 31 | Q5C9Z4 | |
| GPKTRAAAGKPGENR | 21 | A8MXQ7 | |
| STPTDGAKKPRGRGR | 1191 | Q9ULL5 | |
| GRPPKKNRSPADAGR | 2861 | Q6ZRS2 | |
| PKRLSRGAQSGPEGR | 616 | Q14162 | |
| KRPAEGKAGSPLKGR | 1731 | Q9H2D6 | |
| GLGPEAAAPGKRIRK | 21 | P25440 | |
| PERGPRGKGKARASQ | 326 | P08913 | |
| PKSSQANPGRHRKRG | 166 | P42695 | |
| KEKPSGRGRGASGRQ | 341 | Q96PV4 | |
| RKSDRKPLRGGGYNP | 151 | Q9BQE4 | |
| KERRAKAQGPRGDLG | 156 | O00294 | |
| GKKDPRARGEEASGP | 221 | O15417 | |
| ARKLRGPKEPGFEAG | 1971 | O15417 | |
| EKKGPGGGAPVRLRS | 491 | Q8N5D0 | |
| RKGSGRRLVKGPDPS | 41 | P07996 | |
| RRVGVPKGAKGSPVN | 396 | Q8NI27 | |
| SARRRGADKAKPPPG | 6 | O43242 | |
| RRAEKGPAKRPTGQK | 491 | Q9NZQ8 | |
| AAAPARQGRKKPAGK | 686 | P38935 | |
| RKRKGIAGPGLPDLS | 6 | Q8WZ04 | |
| SAQGPGRVGPRRQRK | 631 | Q9P2H5 | |
| GKAEGGKRPARGAPQ | 391 | Q07617 | |
| DRGRGPNGKERKPKH | 1346 | O60281 | |
| GRKLSLRRKADGPPG | 776 | Q4KMP7 | |
| RQGGKAPVTPRGRGR | 1386 | Q12888 | |
| KPPRRKGNNQAEAGG | 141 | Q1RN00 | |
| AFRGVRRPGAPGQKA | 3421 | Q96JG9 | |
| RRPGAPGQKARALEG | 3426 | Q96JG9 | |
| PTRVPKAGAKAGRQG | 326 | Q969Z4 | |
| ERGRKKIKAENPGGP | 191 | Q5T0B9 | |
| RRGPGSRRKVPGQFS | 286 | Q8TEC5 | |
| RQQPPSGKRGGRKRR | 26 | Q15672 | |
| RRRECTAPAPKNGGK | 336 | O95185 | |
| RVGKAGTNKPPRCRG | 386 | Q8N5A5 | |
| KGRQRKPRPLDPGEG | 46 | Q9H1B5 | |
| KSGGRLGSPKPERQR | 861 | Q86VM9 | |
| KSGDSGDRPGQKRFR | 2936 | Q15911 | |
| PRVGNRRGPAGKKAP | 136 | Q86VY4 | |
| QRPRGPKDGAGRKVC | 71 | Q6UXQ8 | |
| PGVPAGAKRNRKTNG | 26 | A6NN73 | |
| VKKENNSPPRARAGG | 711 | Q5VV43 | |
| FRTRGSGRKQPGNPK | 556 | Q8WXH2 |